Our Pricing

Understanding Weight Loss on Saxenda: Clinical Evidence and Patient Outcomes

Published on: June 03, 2026

Weight loss on Saxenda (liraglutide 3mg) has been extensively studied in clinical trials, with patients achieving meaningful reductions in body weight when combined with lifestyle modifications. As a GLP-1 receptor agonist, Saxenda works by regulating appetite and slowing gastric emptying, helping patients feel fuller for longer periods. At Cured Pharmacy, we provide Saxenda from £124.99 following a free online consultation with our UK-registered prescribers.

How Weight Loss on Saxenda Works: The Science Behind Liraglutide

Weight loss on Saxenda occurs through liraglutide's action on GLP-1 receptors in the brain's appetite control centres. This daily injection mimics the natural hormone GLP-1, which signals satiety after meals and reduces hunger between eating occasions [1]. Unlike many weight loss treatments, Saxenda addresses the physiological mechanisms that regulate body weight rather than simply suppressing appetite artificially.

The medication is administered as a subcutaneous injection once daily, with doses gradually increased from 0.6mg to the maintenance dose of 3mg over five weeks. This titration schedule minimises gastrointestinal side effects whilst allowing your body to adjust to the medication's effects [2]. Patients typically begin noticing changes in appetite within the first week, though measurable weight loss on Saxenda generally becomes evident after 4-8 weeks of treatment.

Mechanism of Action for Weight Loss on Saxenda

Liraglutide binds to GLP-1 receptors in pancreatic beta cells, the gastrointestinal tract, and crucially, in hypothalamic regions controlling appetite. This multi-site action explains why weight loss on Saxenda involves both reduced caloric intake and improved metabolic parameters [1]. The medication slows gastric emptying by approximately 30-40 minutes per meal, extending the feeling of fullness and reducing portion sizes naturally.

Clinical pharmacology studies demonstrate that Saxenda maintains therapeutic plasma concentrations for 24 hours following injection, providing consistent appetite regulation throughout the day and night. This sustained action differentiates weight loss on Saxenda from shorter-acting appetite suppressants that may cause rebound hunger between doses.

Expected Weight Loss on Saxenda: Clinical Trial Data and Real-World Results

The landmark SCALE trials evaluated weight loss on Saxenda across diverse patient populations, demonstrating that participants lost an average of 8-10% of their initial body weight over 56 weeks [3]. In the SCALE Obesity and Prediabetes trial, 63.2% of patients achieved at least 5% weight loss, whilst 33.1% lost 10% or more of their starting weight when combining Saxenda with reduced-calorie diet and increased physical activity.

Real-world outcomes for weight loss on Saxenda often mirror these clinical findings, though individual results vary based on adherence, baseline BMI, and lifestyle modifications. Patients with BMI 30-35 kg/m² typically see 6-8kg reduction in the first six months, whilst those with higher starting BMI may achieve 10-15kg weight loss [3]. Our clinical team at Cured Pharmacy monitors progress through regular check-ins to optimise treatment outcomes.

Optimising Weight Loss on Saxenda: Dosing, Diet, and Lifestyle Integration

Successful weight loss on Saxenda requires a structured approach combining medication with behavioural changes. The standard titration schedule begins at 0.6mg daily for week one, increasing by 0.6mg increments weekly until reaching the 3mg maintenance dose by week five [2]. This gradual escalation allows your digestive system to adapt whilst minimising nausea and other gastrointestinal effects that could compromise adherence.

Dietary modifications significantly enhance weight loss on Saxenda, with research showing that patients following a 500-calorie daily deficit achieve 30-40% greater weight reduction than those relying on medication alone [4]. We recommend focusing on high-protein, high-fibre meals that complement Saxenda's satiety effects, alongside at least 150 minutes of moderate-intensity physical activity weekly. Our prescribers provide personalised guidance on integrating these lifestyle changes during your initial consultation.

Injection Technique for Optimal Weight Loss on Saxenda

Proper injection technique ensures consistent absorption and maximises weight loss on Saxenda. The medication should be injected subcutaneously into the abdomen, thigh, or upper arm, rotating injection sites to prevent lipohypertrophy. Each pre-filled pen delivers precise doses using a simple dial mechanism, with ultra-fine needles minimising discomfort.

Timing flexibility represents a practical advantage for weight loss on Saxenda—you can administer your daily injection at any time, though maintaining a consistent schedule optimises habit formation. Many patients prefer morning injections to leverage appetite suppression throughout their most challenging eating periods, whilst others find evening administration more convenient for their routine.

Side Effects and Safety Considerations for Weight Loss on Saxenda

The most common side effects affecting weight loss on Saxenda are gastrointestinal in nature, including nausea (39% of patients), diarrhoea (21%), constipation (20%), and vomiting (16%) during clinical trials [2]. These symptoms typically peak during dose escalation and diminish significantly after 4-6 weeks as tolerance develops. Starting with smaller portions and avoiding high-fat meals can reduce the severity of these effects.

Serious adverse events are rare but include potential pancreatitis, gallbladder disease, and increased heart rate. Weight loss on Saxenda is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [2]. Our prescribers conduct thorough medical screening during your online consultation to ensure Saxenda is safe and appropriate for your individual circumstances.

Comparing Weight Loss on Saxenda Versus Other GLP-1 Treatments

When evaluating weight loss on Saxenda against newer GLP-1 receptor agonists, head-to-head trials show nuanced differences. Semaglutide (Wegovy) demonstrated superior weight reduction in the STEP trials, with average losses of 12-15% versus 8-10% for Saxenda [5]. However, weight loss on Saxenda occurs with daily injections that some patients prefer for dose flexibility, versus weekly semaglutide injections.

Tirzepatide (Mounjaro) combines GLP-1 and GIP receptor agonism, achieving even greater weight loss on Saxenda in comparative analyses—up to 20% body weight reduction in SURPASS trials [6]. Despite these differences, weight loss on Saxenda remains highly effective for patients seeking proven results with extensive real-world safety data spanning over a decade of clinical use. The choice between treatments depends on individual response, tolerance, cost considerations, and prescriber guidance.

Cost-Effectiveness of Weight Loss on Saxenda

At Cured Pharmacy, we offer Saxenda from £124.99 representing the cheapest UK price for this clinically-proven treatment. This transparent pricing includes your medication and free prescriber consultation, with no hidden fees or subscription requirements. When comparing cost per kilogram of weight lost, weight loss on Saxenda delivers competitive value given its established efficacy profile and flexible daily dosing.

Patients can use discount code Weightlossnew to Save £20 on their first order, further improving affordability. Our commitment to lowest prices guaranteed ensures you receive genuine UK-licensed Saxenda without compromising on clinical support or medication quality.

Long-Term Maintenance and Sustainability of Weight Loss on Saxenda

Sustaining weight loss on Saxenda beyond the initial treatment phase requires ongoing medication use combined with maintained lifestyle changes. The SCALE Maintenance trial followed patients for three years, demonstrating that continued Saxenda use prevented weight regain, whilst those discontinuing treatment regained approximately 50-70% of lost weight within 12 months [7]. This underscores the chronic nature of obesity and the role of pharmacotherapy in long-term weight management.

Our clinical team recommends regular progress reviews every 12-16 weeks to assess whether weight loss on Saxenda continues meeting treatment goals. NICE guidance suggests discontinuing Saxenda if patients fail to lose at least 5% of initial body weight after 12 weeks at the maintenance dose [8]. However, most patients who achieve early weight loss on Saxenda continue benefiting from treatment with sustained reductions in body weight and improvements in metabolic markers.

Transitioning off Saxenda should be planned carefully with prescriber guidance, incorporating intensified lifestyle interventions to minimise rebound weight gain. Some patients maintain their weight loss on Saxenda achievements through reduced dosing schedules, though this approach requires individualised assessment and monitoring. At Cured Pharmacy, we provide ongoing support throughout your weight management journey, ensuring you have the clinical guidance needed for lasting success.

Scientific References

1. van Can, J., Sloth, B., Jensen, C. B., Flint, A., Blaak, E. E., & Saris, W. H. (2014). Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. International Journal of Obesity, 38(6), 784-793. [accessed 13 August 2026]
2. Electronic Medicines Compendium. (2023). Saxenda 6 mg/ml solution for injection in pre-filled pen - Summary of Product Characteristics. Novo Nordisk Limited. [accessed 13 August 2026]
3. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 13 August 2026]
4. Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V., Hale, P. M., & Aronne, L. (2013). Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. International Journal of Obesity, 37(11), 1443-1451. [accessed 13 August 2026]
5. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 13 August 2026]
6. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 13 August 2026]
7. Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V., Hale, P. M., & Aronne, L. (2013). Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. International Journal of Obesity, 37(11), 1443-1451. [accessed 13 August 2026]
8. National Institute for Health and Care Excellence. (2020). Liraglutide for managing overweight and obesity. Technology appraisal guidance [TA664]. [accessed 13 August 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.